SCHEMBL10502250

SCHEMBL10502250

COc1cccc2[se]n(-c3ccccc3)c(=S)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ PRNP P04156 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ NCOA2 Q15596 1/20 0.39
▸ NCOA1 Q15788 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ APOBEC3G Q9HC16 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ QSOX1 O00391 1/20 0.38
▸ RGS12 O14924 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10503581 0.82 METAP2 (0.53) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL10747373 0.79 METAP2 (0.37) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL10502502 0.79 MAPT (0.40) METAP2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10501731 0.76 METAP2 (0.38) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL10501858 0.74 KDM4E (0.40) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL11025076 0.71 TDP1 (0.40) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL10501589 0.70 METAP2 (0.61) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL10501336 0.69 METAP2 (0.50) METAP2ALDH1A1KDM4EHPGDLMNA
SCHEMBL10501283 0.68 METAP2 (0.68) METAP2ALDH1A1HPGDKMT2AMEN1
SCHEMBL10501696 0.65 METAP2 (0.46) METAP2ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback